{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:54:24Z","timestamp":1788656064432,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Behav Neurosci Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40473-020-00221-6","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T04:03:31Z","timestamp":1602216211000},"page":"278-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["New Developments in Cholinergic Imaging in Alzheimer and Lewy Body Disorders"],"prefix":"10.1007","volume":"7","author":[{"given":"Chesney E.","family":"Craig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn L. T. M.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0352-6414","authenticated-orcid":false,"given":"Nicolaas I.","family":"Bohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"221_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","volume":"7","author":"NI Bohnen","year":"2018","unstructured":"Bohnen NI, Grothe MJ, Ray NJ, M\u00fcller MLTM, Teipel SJ. Recent advances in cholinergic imaging and cognitive decline\u2014revisiting the cholinergic hypothesis of dementia. Curr Geriatr Rep. 2018;7:1\u201311.","journal-title":"Curr Geriatr Rep"},{"key":"#cr-split#-221_CR2.1","doi-asserted-by":"crossref","unstructured":"Bohnen NI, Kanel P, M\u00fcller MLTM (2018) Molecular imaging of the cholinergic system in Parkinson's disease. In: Politis M, editor. International Review of Neurobiology [Internet]. Academic Press","DOI":"10.1016\/bs.irn.2018.07.027"},{"key":"#cr-split#-221_CR2.2","unstructured":"[cited 2020 Mar 25]. p. 211-50. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0074774218300564"},{"key":"221_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2012.02.083","volume":"514","author":"V Kotagal","year":"2012","unstructured":"Kotagal V, M\u00fcller MLTM, Kaufer DI, Koeppe RA, Bohnen NI. Thalamic cholinergic innervation is spared in Alzheimer disease compared to Parkinsonian disorders. Neurosci Lett. 2012;514:169\u201372.","journal-title":"Neurosci Lett"},{"key":"221_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.116.176180","volume":"58","author":"J Maz\u00e8re","year":"2017","unstructured":"Maz\u00e8re J, Lamare F, Allard M, Fernandez P, Mayo W. 123I-Iodobenzovesamicol SPECT imaging of cholinergic systems in dementia with Lewy bodies. J Nucl Med. 2017;58:123\u20138.","journal-title":"J Nucl Med"},{"key":"221_CR5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41380-018-0130-5","volume":"24","author":"S Nejad-Davarani","year":"2019","unstructured":"Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, M\u00fcller MLTM, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV. Mol Psychiatry. 2019;24:322\u20137.","journal-title":"Mol Psychiatry"},{"key":"221_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/brain\/awx310","volume":"141","author":"NJ Ray","year":"2018","unstructured":"\u2022\u2022 Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, et al. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson\u2019s disease. Brain. 2018;141:165\u201376 First study to demonstrate that baseline Ch4 volumes in de novo PD could predict risk of MCI over 5\u00a0years. In agreement with the AD literature, deterioration in the posterior Ch4 (Ch4p) may be characteristic of MCI in PD, as only volumes in this region could differentiate PD with suspected MCI from controls at baseline.","journal-title":"Brain"},{"key":"221_CR7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0079-6123(08)62112-3","volume":"109","author":"MM Mesulam","year":"1996","unstructured":"Mesulam MM. The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer\u2019s disease. Prog Brain Res. 1996;109:285\u201397.","journal-title":"Prog Brain Res"},{"key":"221_CR8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cne.902140206","volume":"214","author":"MM Mesulam","year":"1983","unstructured":"Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol. 1983;214:170\u201397.","journal-title":"J Comp Neurol"},{"key":"221_CR9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","volume":"10","author":"M-M Mesulam","year":"1983","unstructured":"Mesulam M-M, Mufson EJ, Wainer BH, Levey AI. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1\u2013Ch6). Neuroscience. 1983;10:1185\u2013201.","journal-title":"Neuroscience."},{"key":"221_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cne.903250107","volume":"325","author":"S Heckers","year":"1992","unstructured":"Heckers S, Geula C, Mesulam MM. Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution. J Comp Neurol. 1992;325:68\u201382.","journal-title":"J Comp Neurol"},{"key":"221_CR11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1515\/revneuro-2016-0008","volume":"27","author":"C Zhang","year":"2016","unstructured":"Zhang C, Zhou P, Yuan T. The cholinergic system in the cerebellum: from structure to function. Rev Neurosci. 2016;27:769\u201376.","journal-title":"Rev Neurosci"},{"key":"221_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0165-0173(82)90011-X","volume":"257","author":"HC Fibiger","year":"1982","unstructured":"Fibiger HC. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. 1982;257:327\u201388.","journal-title":"Brain Res"},{"key":"221_CR13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903230209","volume":"323","author":"MM Mesulam","year":"1992","unstructured":"Mesulam MM, Mash D, Hersh L, Bothwell M, Geula C. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus. J Comp Neurol. 1992;323:252\u201368.","journal-title":"J Comp Neurol"},{"key":"221_CR14","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1523\/JNEUROSCI.5071-13.2014","volume":"34","author":"D Dautan","year":"2014","unstructured":"Dautan D, Huerta-Ocampo I, Witten IB, Deisseroth K, Bolam JP, Gerdjikov T, et al. A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem. J Neurosci. 2014;34:4509\u201318.","journal-title":"J Neurosci"},{"key":"221_CR15","doi-asserted-by":"crossref","unstructured":"Dautan D, Hacio\u011flu Bay H, Bolam JP, Gerdjikov TV, Mena-Segovia J (2016) Extrinsic sources of cholinergic innervation of the striatal complex: a whole-brain mapping analysis. Front Neuroanat [Internet]. [cited 2020 Jun 10];10. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4722731\/","DOI":"10.3389\/fnana.2016.00001"},{"key":"221_CR16","first-page":"649","volume":"37","author":"T Irie","year":"1996","unstructured":"Irie T, Fukushi K, Namba H, Iyo M, Tamagami H, Nagatsuka S, et al. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer\u2019s disease. J Nucl Med. 1996;37:649\u201355.","journal-title":"J Nucl Med"},{"key":"221_CR17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00406286","volume":"69","author":"CC Shute","year":"1966","unstructured":"Shute CC, Lewis PR. Electron microscopy of cholinergic terminals and acetylcholinesterase-containing neurones in the hippocampal formation of the rat. Z Zellforsch Mikrosk Anat. 1966;69:334\u201343.","journal-title":"Z Zellforsch Mikrosk Anat"},{"key":"221_CR18","unstructured":"Petrou M, Koeppe R, Scott P, Bohnen N, Kilbourn M, Frey K (2012) PET imaging of the vesicular acetylcholine transporter. J Nucl Med. Society of Nuclear Medicine; 53:290\u2013290."},{"key":"221_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","volume":"129","author":"AKL Liu","year":"2015","unstructured":"Liu AKL, Chang RC-C, Pearce RKB, Gentleman SM. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol. 2015;129:527\u201340.","journal-title":"Acta Neuropathol"},{"key":"221_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainres.2017.06.023","volume":"1670","author":"G Pepeu","year":"2017","unstructured":"Pepeu G, Grazia GM. The fate of the brain cholinergic neurons in neurodegenerative diseases. Brain Res. 2017;1670:173\u201384.","journal-title":"Brain Res"},{"key":"221_CR21","first-page":"2626","volume":"128","author":"SJ Teipel","year":"2005","unstructured":"Teipel SJ, Flatz WH, Heinsen H, Bokde ALW, Schoenberg SO, St\u00f6ckel S, et al. Measurement of basal forebrain atrophy in Alzheimer\u2019s disease using MRI. Brain Oxford Academic. 2005;128:2626\u201344.","journal-title":"Brain Oxford Academic"},{"key":"221_CR22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3233\/JAD-132345","volume":"40","author":"I Kilimann","year":"2014","unstructured":"Kilimann I, Grothe M, Heinsen H, Alho EJL, Grinberg L, Amaro E, et al. Subregional basal forebrain atrophy in Alzheimer\u2019s disease: a multicenter study. J Alzheimers Dis. 2014;40:687\u2013700.","journal-title":"J Alzheimers Dis"},{"key":"221_CR23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuroimage.2008.05.055","volume":"42","author":"L Zaborszky","year":"2008","unstructured":"Zaborszky L, Hoemke L, Mohlberg H, Schleicher A, Amunts K, Zilles K. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage. 2008;42:1127\u201341.","journal-title":"Neuroimage."},{"key":"221_CR24","first-page":"1841","volume":"27","author":"I Kilimann","year":"2017","unstructured":"Kilimann I, Hausner L, Fellgiebel A, Filippi M, W\u00fcrdemann TJ, Heinsen H, et al. Parallel atrophy of cortex and basal forebrain cholinergic system in mild cognitive impairment. Cereb Cortex Oxford Academic. 2017;27:1841\u20138.","journal-title":"Cereb Cortex Oxford Academic"},{"key":"221_CR25","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/brain\/awn075","volume":"131","author":"L Zrinzo","year":"2008","unstructured":"Zrinzo L, Zrinzo LV, Tisch S, Limousin PD, Yousry TA, Afshar F, et al. Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain. 2008;131:1588\u201398.","journal-title":"Brain."},{"key":"221_CR26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mds.27561","volume":"34","author":"F Gargouri","year":"2019","unstructured":"Gargouri F, Gallea C, Mongin M, Pyatigorskaya N, Valabregue R, Ewenczyk C, et al. Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson\u2019s disease. Mov Disord. 2019;34:516\u201325.","journal-title":"Mov Disord"},{"key":"221_CR27","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cne.24541","volume":"526","author":"RL Albin","year":"2018","unstructured":"\u2022\u2022 Albin RL, Bohnen NI, Muller MLTM, Dauer WT, Sarter M, Frey KA, et al. Regional vesicular acetylcholine transporter distribution in human brain: A [18 F]fluoroethoxybenzovesamicol positron emission tomography study. J Comp Neurol. 2018;526:2884\u201397 First anatomic study identifying previously unrecognized small structures with prominent cholinergic innervation, such as the lateral geniculate nucleus and the flocculonodular lobules.","journal-title":"J Comp Neurol."},{"key":"221_CR28","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s00415-015-7827-z","volume":"262","author":"SJ Colloby","year":"2015","unstructured":"Colloby SJ, McKeith IG, Wyper DJ, O\u2019Brien JT, Taylor J-P. Regional covariance of muscarinic acetylcholine receptors in Alzheimer\u2019s disease using (R, R) [(123)I]-QNB SPECT. J Neurol. 2015;262:2144\u201353.","journal-title":"J Neurol"},{"key":"221_CR29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2016.07.017","volume":"47","author":"SJ Colloby","year":"2016","unstructured":"Colloby SJ, Field RH, Wyper DJ, O\u2019Brien JT, Taylor J-P. A spatial covariance 123I-5IA-85380 SPECT study of \u03b14\u03b22 nicotinic receptors in Alzheimer\u2019s disease. Neurobiol Aging. 2016;47:83\u201390.","journal-title":"Neurobiol Aging"},{"key":"221_CR30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.0000000000002839","volume":"87","author":"SJ Colloby","year":"2016","unstructured":"Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O\u2019Brien JT, Taylor J-P. Cholinergic and perfusion brain networks in Parkinson disease dementia. Neurology. 2016;87:178\u201385.","journal-title":"Neurology."},{"key":"221_CR31","doi-asserted-by":"crossref","unstructured":"Kanel P, M\u00fcller MLTM, van der Zee S, Sanchez-Catasus CA, Koeppe RA, Frey KA, et al. (2020) Topography of cholinergic changes in dementia with Lewy bodies and key neural network hubs. JNP. American Psychiatric Publishing; appi.neuropsych.19070165.","DOI":"10.1176\/appi.neuropsych.19070165"},{"key":"221_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.sleep.2018.12.020","volume":"58","author":"M-A Bedard","year":"2019","unstructured":"Bedard M-A, Aghourian M, Legault-Denis C, Postuma RB, Soucy J-P, Gagnon J-F, et al. Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with 18F-FEOBV. Sleep Med. 2019;58:35\u201341.","journal-title":"Sleep Med"},{"key":"221_CR33","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/ncomms13249","volume":"7","author":"TW Schmitz","year":"2016","unstructured":"\u2022\u2022 Schmitz TW, Spreng RN, Weiner MW, Aisen P, Petersen R, Jack CR, et al. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer\u2019s pathology. Nature Communications. 2016;7:13249 First paper to demonstrate that Ch4 (Ch4) degeneration precedes and predicts EC degeneration, which in turn predicts memory impairment in AD pathology. The authors provide compelling evidence for an updated model of AD pathophysiology.","journal-title":"Nature Communications"},{"key":"221_CR34","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/brain\/awaa012","volume":"143","author":"S Fern\u00e1ndez-Cabello","year":"2020","unstructured":"\u2022\u2022 Fern\u00e1ndez-Cabello S, Kronbichler M, KRA VD, Goodman JA, Spreng RN, Schmitz TW. Basal forebrain volume reliably predicts the cortical spread of Alzheimer\u2019s degeneration. Brain. 2020;143:993\u20131009 Building on their previous research [33], the authors present further evidence in two independent samples (N\u2009>\u2009800 combined) that Ch4 atrophy predicts EC atrophy, which in turn predicts neocortical atrophy over 2\u00a0years. Additionally, they report that CSF pTau\/amyloid-\u03b2 ratios moderated this predictive relationship.","journal-title":"Brain"},{"key":"221_CR35","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/cercor\/bhz224","volume":"30","author":"JL Cantero","year":"2020","unstructured":"Cantero JL, Atienza M, Lage C, Zaborszky L, Vilaplana E, Lopez-Garcia S, et al. Atrophy of basal forebrain initiates with tau pathology in individuals at risk for Alzheimer\u2019s disease. Cereb Cortex. Oxford Academic. 2020;30:2083\u201398.","journal-title":"Cereb Cortex. Oxford Academic"},{"key":"221_CR36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.celrep.2018.06.001","volume":"24","author":"TW Schmitz","year":"2018","unstructured":"Schmitz TW, Mur M, Aghourian M, Bedard M-A, Spreng RN. Longitudinal Alzheimer\u2019s degeneration reflects the spatial topography of cholinergic basal forebrain projections. Cell Rep. 2018;24:38\u201346.","journal-title":"Cell Rep"},{"key":"221_CR37","doi-asserted-by":"crossref","unstructured":"Barrett MJ, Sperling SA, Blair JC, Freeman CS, Flanigan JL, Smolkin ME, et al. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease. J Neurol Neurosurg Psychiatry. BMJ Publishing Group Ltd; 2019;90:1251\u20131256.","DOI":"10.1136\/jnnp-2019-320450"},{"key":"221_CR38","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz J, Pagano G, Fern\u00e1ndez Bonfante JA, Wilson H, Politis M. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain. 2018;141:1501\u201316.","journal-title":"Brain."},{"key":"221_CR39","doi-asserted-by":"crossref","first-page":"104831","DOI":"10.1016\/j.nbd.2020.104831","volume":"139","author":"JB Pereira","year":"2020","unstructured":"\u2022\u2022 Pereira JB, Hall S, Jalakas M, Grothe MJ, Strandberg O, Stomrud E, et al. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson\u2019s disease. Neurobiol Dis. 2020;139:104831 First longitudinal study examining GM cBF volumes over a 10-year period in patients with PD, PDD and controls. At baseline, PDD and those who would convert to PDD later showed significant Ch4 atrophy compared to controls. Both PDD groups showed Ch1\/2 atrophy over time compared with controls and PD-stable. Longitudinal changes in Ch4 volumes significantly predicted conversion to PDD over 10\u00a0years.","journal-title":"Neurobiol Dis."},{"key":"221_CR40","first-page":"2039","volume":"40","author":"KD Jethwa","year":"2019","unstructured":"\u2022 Jethwa KD, Dhillon P, Meng D, Auer DP. Alzheimer\u2019s disease neuroimaging initiative. Are linear measurements of the nucleus basalis of Meynert suitable as a diagnostic biomarker in mild cognitive impairment and alzheimer disease? AJNR Am J Neuroradiol. 2019;40:2039\u201344 This paper provides initial evidence that a simple linear measurement of Ch4 thickness could show clinical promise to differentiate controls from those with AD and late MCI. The paper below [41] further developed on this technique by using susceptibility weighted phase sensitive inversion recovery (SW-PSIR) to improve Ch4 contrast resolution and interrater reliability of Ch4 thickness.","journal-title":"AJNR Am J Neuroradiol."},{"key":"221_CR41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mri.2019.06.004","volume":"61","author":"KD Jethwa","year":"2019","unstructured":"Jethwa KD, Aphiwatthanasumet K, Mougin O, Bowtell R, Auer D, Gowland P. Phase enhanced PSIR T1 weighted imaging improves contrast resolution of the nucleus basalis of Meynert at 7 T: a preliminary study. Magn Reson Imaging. 2019;61:296\u20139.","journal-title":"Magn Reson Imaging"},{"key":"221_CR42","doi-asserted-by":"crossref","unstructured":"\u2022 Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, et al. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer\u2019s disease. Scientific Reports. Nature Publishing Group; 2017;7:11706. First study to assess the effect of cholinergic medication on cBF integrity in AD. The acetylcholinesterase inhibitor (AChEI), Donepezil, significantly reduced annual cBF GM atrophy in patients with prodromal AD, with the largest treatment effects witnessed in Ch4 (Ch4) and Ch1\/2.","DOI":"10.1038\/s41598-017-09780-3"},{"key":"221_CR43","doi-asserted-by":"crossref","first-page":"116607","DOI":"10.1016\/j.neuroimage.2020.116607","volume":"211","author":"M Nemy","year":"2020","unstructured":"Nemy M, Cedres N, Grothe MJ, Muehlboeck J-S, Lindberg O, Nedelska Z, et al. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. Neuroimage. 2020;211:116607.","journal-title":"Neuroimage."},{"key":"221_CR44","first-page":"47","volume":"9","author":"Q Liu","year":"2017","unstructured":"Liu Q, Zhu Z, Teipel SJ, Yang J, Xing Y, Tang Y, et al. White matter damage in the cholinergic system contributes to cognitive impairment in subcortical vascular cognitive impairment. No Dementia Front Aging Neurosci. 2017;9:47.","journal-title":"No Dementia Front Aging Neurosci"},{"key":"221_CR45","first-page":"2545","volume":"141","author":"JH Lanskey","year":"2018","unstructured":"Lanskey JH, McColgan P, Schrag AE, Acosta-Cabronero J, Rees G, Morris HR, et al. Can neuroimaging predict dementia in Parkinson\u2019s disease? Brain. 2018;141:2545\u201360.","journal-title":"Brain."},{"key":"221_CR46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","volume":"20","author":"MA Hely","year":"2005","unstructured":"Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney multicenter study of Parkinson\u2019s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20:190\u20139.","journal-title":"Mov Disord"},{"key":"221_CR47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","volume":"77","author":"DJ Burn","year":"2006","unstructured":"Burn DJ, Rowan EN, Allan LM, Molloy S, O\u2019Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77:585\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"221_CR48","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen NI, M\u00fcller MLTM, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 2009;73:1670\u20136.","journal-title":"Neurology."},{"key":"221_CR49","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","volume":"81","author":"NI Bohnen","year":"2013","unstructured":"\u2022 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJH, et al. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 2013;81:1611\u20136 Our recent paper shows for the first time distinct subcortical cholinergic system changes between PD fallers vs. freezers.","journal-title":"Neurology"},{"key":"221_CR50","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.25430","volume":"85","author":"NI Bohnen","year":"2019","unstructured":"Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, et al. Cholinergic system changes of falls and freezing of gait in Parkinson\u2019s disease. Ann Neurol. 2019;85:538\u201349.","journal-title":"Ann Neurol"},{"key":"221_CR51","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/WNR.0b013e32833ce5f1","volume":"21","author":"PM Schweder","year":"2010","unstructured":"Schweder PM, Hansen PC, Green AL, Quaghebeur G, Stein J, Aziz TZ. Connectivity of the pedunculopontine nucleus in parkinsonian freezing of gait. Neuroreport. 2010;21:914\u20136.","journal-title":"Neuroreport."},{"key":"221_CR52","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/brain\/awt172","volume":"136","author":"BW Fling","year":"2013","unstructured":"Fling BW, Cohen RG, Mancini M, Nutt JG, Fair DA, Horak FB. Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain. 2013;136:2405\u201318.","journal-title":"Brain."},{"key":"221_CR53","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00429-016-1356-0","volume":"222","author":"ATDL Alho","year":"2017","unstructured":"Alho ATDL, Hamani C, Alho EJL, da Silva RE, Santos GAB, Neves RC, et al. Magnetic resonance diffusion tensor imaging for the pedunculopontine nucleus: proof of concept and histological correlation. Brain Struct Funct. 2017;222:2547\u201358.","journal-title":"Brain Struct Funct"},{"key":"221_CR54","doi-asserted-by":"crossref","unstructured":"\u2022 Craig CE, Jenkinson NJ, Brittain J-S, Grothe MJ, Rochester L, Silverdale M, et al. (2020) Pedunculopontine nucleus microstructure predicts postural and gait symptoms in Parkinson\u2019s disease. Mov Disord. Our recent paper demonstrated how a novel MRI measure of PPN microstructural integrity may provide a non-invasive biomarker of PIGD from early PD. Results showed that axial diffusivity (aD) in the PPN, but not Ch4, predicted future PIGD symptoms in PD.","DOI":"10.1002\/mds.28051"},{"key":"221_CR55","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1002\/mds.21912","volume":"23","author":"AL Bartels","year":"2008","unstructured":"Bartels AL, Leenders KL. Brain imaging in patients with freezing of gait. Mov Disord. 2008;23:S461\u20137.","journal-title":"Mov Disord"},{"key":"221_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/brain\/awq324","volume":"134","author":"AH Snijders","year":"2011","unstructured":"Snijders AH, Leunissen I, Bakker M, Overeem S, Helmich RC, Bloem BR, et al. Gait-related cerebral alterations in patients with Parkinson\u2019s disease with freezing of gait. Brain. 2011;134:59\u201372.","journal-title":"Brain."},{"key":"221_CR57","doi-asserted-by":"crossref","unstructured":"Peterson DS, Pickett KA, Duncan R, Perlmutter J, Earhart GM (2014) Gait-related brain activity in people with Parkinson disease with freezing of gait. PLoS One [Internet]. [cited 2020 Jun 10];9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3940915\/","DOI":"10.1371\/journal.pone.0090634"},{"key":"221_CR58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1073858413494269","volume":"20","author":"S Vossel","year":"2014","unstructured":"Vossel S, Geng JJ, Fink GR. Dorsal and ventral attention systems: distinct neural circuits but collaborative roles. Neuroscientist. 2014;20:150\u20139.","journal-title":"Neuroscientist."},{"key":"221_CR59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/brain\/119.1.79","volume":"119","author":"G Ebersbach","year":"1996","unstructured":"Ebersbach G, Trottenberg T, H\u00e4ttig H, Schelosky L, Schrag A, Poewe W. Directional bias of initial visual exploration: a symptom of neglect in Parkinson\u2019s disease. Brain. Oxford Academic. 1996;119:79\u201387.","journal-title":"Brain"},{"key":"221_CR60","doi-asserted-by":"crossref","unstructured":"Dieterich M, Bense S, Lutz S, Drzezga A, Stephan T, Bartenstein P, et al. Dominance for vestibular cortical function in the non-dominant hemisphere. Cerebral Cortex. United Kingdom: Oxford University Press; 2003;13:994\u20131007.","DOI":"10.1093\/cercor\/13.9.994"},{"key":"221_CR61","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/cercor\/bhv062","volume":"26","author":"MJ Grothe","year":"2016","unstructured":"Grothe MJ, Heinsen H, Amaro E, Grinberg LT, Teipel SJ. Cognitive correlates of basal forebrain atrophy and associated cortical hypometabolism in mild cognitive impairment. Cereb Cortex. 2016;26:2411\u201326.","journal-title":"Cereb Cortex"},{"key":"221_CR62","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","volume":"91","author":"EC Ballinger","year":"2016","unstructured":"Ballinger EC, Ananth M, Talmage DA, Role LW. Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron. 2016;91:1199\u2013218.","journal-title":"Neuron."}],"container-title":["Current Behavioral Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40473-020-00221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40473-020-00221-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40473-020-00221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:30:28Z","timestamp":1633847428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40473-020-00221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s40473-020-00221-6","relation":{},"ISSN":["2196-2979"],"issn-type":[{"value":"2196-2979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"30 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}